HOME >> BIOLOGY >> NEWS
Ethical guidelines needed before 'nutrigenomic' groceries come to market

enlarging already huge inequities in health status and disease burden both within developed nations, and especially between developed and developing countries.

If nutritional genomics testing turns out to be valuable for health care, there will be pressure on governments to fund the tests. As a general principle, the higher the predictive value of the nutrigenetic test, and the more effective known interventions are, the clearer the practitioner's duty to offer the test and society's obligation to fund it.

Regulation and oversight

Governments are looking at what if any regulations are needed to cover issues in this field, including scientific research, consent, counseling, testing technology and standards, who gets to provide nutritional genomics services, and access to nutritional genomics information.

Governments have a wide range of options. The most open would be to leave the issue to the market, as is now the case for home pregnancy testing kits or genetic testing to establish parentage. Moving up a step, governments could require or professional groups or the industry could unilaterally establish voluntary codes of practice. The most severe level of would be strict regulation, similar to that covering prescription drugs or HIV testing. This level might be applied only to testing that has a high potential psychological impact on a person or that requires extensive analysis or interpretation.

As nutritional genomics research zeroes in on more specific links between specific foods and diseases, the line between foods and drugs may become more blurred. This could pose challenges for governments, which have tended to regulate food and drugs differently. Governments are already grappling with what health benefits foods should be permitted to claim, and how these claims should be communicated to the public.

Because some of these "foods" make claims that enter the terrain traditionally limited to drugs, governments n
'"/>


3-Nov-2003


Page: 1 2 3 4 5 6 7 8

Related biology news :

1. NHGRI launches Centers for Excellence in Ethical, Legal, and Social Implications Research
2. New guidelines show significant benefits of FUZEON for wide range of pre-treated HIV/AIDS patients
3. International critical care doctors release first-ever guidelines for sepsis
4. Revised guidelines published for testing for hereditary type of colorectal cancer
5. New ACOG guidelines on progesterone to prevent preterm birth praised by March of Dimes
6. New guidelines can help health officials better predict and control dengue epidemics
7. Researchers develop guidelines to establish identity of genes responsible for complex diseases
8. Aborigine study suggests body mass index guidelines should be lower to block diabetes
9. New nutrition guidelines for diabetics promote emphasis on high-monounsaturated fat diet
10. Conservation International and Starbucks announce new coffee sourcing guidelines
11. Report on dietary supplements containing ephedra makes urgent call for research to develop dose guidelines, safety warnings

Post Your Comments:
(Date:10/22/2014)... Medicine® scientists helps explain how bipolar disorder affects the ... therapies to treat the mental illness. , Scientists ... method recognized with the 2014 Nobel Prize in ... from mice with bipolar-like behaviors. In the synapses (where ... structures with concentrated levels of ANK3 -- the gene ...
(Date:10/22/2014)... , Oct. 20, 2014  Leading identity analyst firm ... half of the world,s population will have a chip-based ... Europe . Asia , ... market accounting for more than 60% of all National ... Acuity,s report  -- "The Global National eID ...
(Date:10/19/2014)... in India over the last 30 years contributed ... growth during that time, according to a new ... Change ., "Energy access is fundamental to development: ... including education, communication, and health," says IIASA researcher ... increased energy access is widely agreed to be ...
Breaking Biology News(10 mins):Bipolar disorder discovery at the nano level 2Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Improved electricity access has little impact on climate change 2
(Date:10/25/2014)... , October 24, 2014 ... Corporation (NASDAQ: CYTR ), Vertex Pharmaceuticals Inc. ... ALXN ), Peregrine Pharmaceuticals Inc. (NASDAQ: ... research on these five companies can be accessed at: ... Thursday, October 23, 2014, ended on a positive note ...
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis ... specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today ... to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., ... for the treatment of diabetic gastroparesis and other GI ... successful Phase 2 trial of relamorelin for the treatment ...
(Date:10/22/2014)... WriteResult, LLC – a premier provider of ... a team of researchers from Yale University’s School of ... to provide electronic questionnaire data collection through use of ... in May, aims to evaluate the impact of a ... and participation in urban agriculture to impact their consumption ...
(Date:10/22/2014)... ROCKVILLE, Md. , Oct. 22, 2014   ... company developing novel pathogen-specific therapies for serious infections and ... Office has issued a Notice of Allowance for a ... product in its C. difficile program, SYN-004. This ... to SYN-004 in the U.S. and adds to the ...
Breaking Biology Technology:Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4
Cached News: